Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease

被引：0
|
作者：
Guillaume Grolez
Caroline Moreau
Bernard Sablonnière
Guillaume Garçon
Jean-Christophe Devedjian
Sayah Meguig
Patrick Gelé
Christine Delmaire
Regis Bordet
Luc Defebvre
Ioav Z Cabantchik
David Devos
机构：
[1] Lille Nord de France University,Department of Medical Pharmacology
[2] Lille Nord de France University,Department of Movement Disorders and Neurology
[3] Lille Nord de France University,INSERM U1171, Lille Faculty of Medicine
[4] Lille University Hospital,Department of Molecular Biology and Pathology Centre, Unit 837, Team 1, INSERM Lille Faculty of Medicine
[5] Lille Nord de France University,Department of Toxicology, Public Health and Environment, EA 4483, Faculty of Pharmaceutic and Biological Sciences
[6] Lille Nord de France University,Biological Resources Centre
[7] Lille University Hospital,Department of Neuroradiology
[8] Lille University Hospital,Della Pergola Chair, Alexander Silberman Institute of Life Sciences
[9] Hebrew University,undefined
来源：
BMC Neurology | / 15卷
关键词：
Parkinson’s disease; Iron chelation; L-dopa; Motor response; Deferiprone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease
    Grolez, Guillaume
    Moreau, Caroline
    Sablonniere, Bernard
    Garcon, Guillaume
    Devedjian, Jean-Christophe
    Meguig, Sayah
    Gele, Patrick
    Delmaire, Christine
    Bordet, Regis
    Defebvre, Luc
    Cabantchik, Ioav Z.
    Devos, David
    [J]. BMC NEUROLOGY, 2015, 15
  • [2] Modifying effect of ceruloplasmin polymorphism on iron chelation response in Parkinson's disease
    Grolez, G.
    Meguig, S.
    Moreau, C.
    Sablonniere, B.
    Strubi-Vuilhaume, I.
    Ryckewaert, G.
    Jissendi, P.
    Hopes, L.
    Dujardin, K.
    Devedjian, J. -C.
    Kluza, J.
    Jonneaux, A.
    Petrault, M.
    Garcon, G.
    Rouaix, N.
    Duhamel, A.
    Auger, F.
    Ravasi, L.
    Firdaus, W.
    Zahr, N.
    Destee, A.
    Corvol, J. -C.
    Poeltl, D.
    Leist, M.
    Rose, C.
    Marchetti, P.
    Cabantchik, I. Z.
    Bordet, R.
    Defebvre, L.
    Devos, D.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 : S294 - S294
  • [3] Modifying effect of ceruloplasmin polymorphism on iron chelation response in Parkinson's disease
    Grolez, G.
    Meguig, S.
    Moreau, C.
    Sablonniere, B.
    Strubi-Vuilhaume, I.
    Ryckewaert, G.
    Jissendi, P.
    Hopes, L.
    Dujardin, K.
    Devedjian, J. -C.
    Kluza, J.
    Jonneaux, A.
    Petrault, M.
    Garcon, G.
    Rouaix, N.
    Duhamel, A.
    Auger, F.
    Ravasi, L.
    Firdaus, W.
    Zahr, N.
    Destee, A.
    Corvol, J. -C.
    Poeltl, D.
    Leist, M.
    Rose, C.
    Marchetti, P.
    Cabantchik, I. Z.
    Bordet, R.
    Defebvre, L.
    Devos, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 444 - 444
  • [4] Modifying effect of ceruloplasmin polymorphism on iron chelation response in Parkinson's disease
    Grolez, G.
    Meguig, S.
    Moreau, C.
    Sablonniere, B.
    Strubi-Vuilhaume, I.
    Ryckewaert, G.
    Jissendi, P.
    Hopes, L.
    Dujardin, K.
    Devedjian, J. -C.
    Kluza, J.
    Laloux, C.
    Jonneaux, A.
    Petrault, M.
    Garcon, G.
    Rouaix, N.
    Duhamel, A.
    Auger, F.
    Ravasi, L.
    Firdaus, W.
    Zahr, N.
    Destee, A.
    Corvol, J. -C.
    Poeltl, D.
    Leist, M.
    Rose, C.
    Marchetti, P.
    Cabantchik, I. Z.
    Bordet, R.
    Defebvre, L.
    Devos, D.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S241 - S241
  • [5] New perspectives in iron chelation therapy for the treatment of Parkinson's disease
    Marco T.Nu?ez
    Pedro Chana-Cuevas
    [J]. Neural Regeneration Research, 2019, 14 (11) : 1905 - 1906
  • [6] New perspectives in iron chelation therapy for the treatment of Parkinson's disease
    Nunez, Marco T.
    Chana-Cuevas, Pedro
    [J]. NEURAL REGENERATION RESEARCH, 2019, 14 (11) : 1905 - 1906
  • [7] Iron chelation in early Parkinson's disease
    Levi, Sonia
    Volonte, Maria Antonietta
    [J]. LANCET NEUROLOGY, 2023, 22 (04): : 290 - 291
  • [8] Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies
    Kristinsson, Jakob
    Snaedal, Jon
    Torsdottir, Gudlaug
    Johannesson, Torkell
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 515 - 521
  • [9] Lack of Benefit of Iron Chelation in Early Parkinson's Disease
    Galasko, Douglas
    Simuni, Tanya
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (22): : 2087 - 2088
  • [10] Is Chelation Therapy a Potential Treatment for Parkinson's Disease?
    Ward, Roberta J.
    Dexter, David T.
    Martin-Bastida, Antonio
    Crichton, Robert R.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
12345